Xaira
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 Gateway Blvd Fl 4, South San Francis...Phone Number
(650) 781-0105Website
www.xaira.comRevenue
$42 MillionIndustry
About Xaira
Xaira Org Chart
Is Xaira your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Xaira had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Xaira recently announced quarterly report
Product Launch: Get notified when Xaira launches new products
Xaira, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Xaira is spiking on competitors!
Check if Xaira has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Xaira has new funding data
Congratulate Masked Content for being promoted to Masked Content at Xaira
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Xaira is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Xaira is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Xaira.
Xaira Tech Stack
A closer look at the technologies used by Xaira
Most Recent Scoops
Xaira News & Media
X-Atlas/Orion: Xaira Therapeutics Unveils Largest Publicly Available Genome-Wide Perturb-seq Dataset to Power Next-Generation AI for Biology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xaira Therapeutics today announced a significant leap forward in developing AI-driven virtual cell models with the release of “X-Atlas/Orion,” the largest publicly available Perturb-seq atlas. This extensive dataset was made possible by Xaira’s concurrently introduced “Fix-Cryopreserve-ScRNAseq” (FiCS) Perturb-seq platform, a highly scalable technology designed for large-scale data generation. These combined advancements are poised to accelerate theXaira Therapeutics Announces the Appointment of Bo Wang as SVP and Head of Biomedical AI
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xaira Therapeutics today announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company’s efforts to develop AI-driven models to help elucidate the molecular basis of poorly treated diseases and to match novel treatments to patients most likely to respond – two major challenges of the drug discovery process. “Throughout his career, Dr. Wang has been at the forefrontXaira Therapeutics bolsters leadership team and relocates headquarters to fuel AI-powered ...
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.Xaira Therapeutics Announces the Appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as Chief Technology Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xaira Therapeutics announces the appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as Chief Technology Officer
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xaira
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to bett... Read More